A recent combined analysis of GWAS results and the Italian replication study provided evidence of association of risk for differentiated thyroid cancer with rs10136427 (BATF, basic leucine zipper ATF-like transcription factor, 14q24.3) with an OR = 1.40, P = 4.35E-07) and rs7267944 (DHX35, DEAH-box helicase 35, 20q12) with an OR 1.39, P = 2.13E-08. This evidence concerns the gene BATF and thyroid gland carcinoma.